Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  Pu, Wang Yang ^a   Zhang, Rong ^a   Xiao, Li ^a   Wu, Yong You ^a   Gong, Wei ^a   Lv, Xiao Dong ^a   Zhong, Feng Yun ^a   Zhuang, Zhi Xiang ^a   Bai, Xu Ming ^a   Li, Kai ^b   Xing, Chun Gen ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Alu qPCR; Circulating cell free DNA; DNA integrity; Gastric cancer

Indexed keywords

CIRCULATING CELL FREE DNA; DNA; MOLECULAR MARKER; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVIEW; STOMACH CANCER; AGED; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; FOLLOW UP; GENETICS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPH NODE METASTASIS; PATHOLOGY; PERITONEAL NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; SECONDARY; STOMACH NEOPLASMS; TUMOR INVASION;

ADULT; AGED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; STOMACH NEOPLASMS;

EID: 85002643188     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2977-7     Document Type: Review

References (19)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917.
2. Marrelli D, Morgagni P, de Manzoni G, Coniglio A, Marchet A, Saragoni L, et al. Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centers. Ann Surg. 2012;255(3):486-91.
3. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426-37.
4. Shapiro B, Chakrabarty M, Cohn EM, Leon SA. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer. 1983;51(11):2116-20.
5. Sai S, Ichikawa D, Tomita H, Ikoma D, Tani N, Ikoma H, et al. Quantification of plasma cell-free DNA in patients with gastric cancer. Anticancer Res. 2007;27(4C):2747-51.
6. Park JL, Kim HJ, Choi BY, Lee HC, Jang HR, Song KS, et al. Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients. Oncol Lett. 2012;3(4):921-6.
7. Kolesnikova EV, Tamkovich SN, Bryzgunova OE, Shelestyuk PI, Permyakova VI, Vlassov VV, et al. Circulating DNA in the blood of gastric cancer patients. Ann N Y Acad Sci. 2008;1137(1):226-31.
8. Balgkouranidou I, Karayiannakis A, Matthaios D, Bolanaki H, Tripsianis G, Tentes AA, et al. Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival. Clin Chem Lab Med. 2013;51(7):1505-10.
9. Hamakawa T, Kukita Y, Kurokawa Y, Miyazaki Y, Takahashi T, Yamasaki M, et al. Monitoring gastric cancer progression with circulating tumour DNA. Br J Cancer. 2015;112(2):352-6.
10. Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol. 2006;24(26):4270-6.
11. Umetani N, Kim J, Hiramatsu S, Reber HA, Hines OJ, Bilchik AJ, et al. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem. 2006;52(6):1062-9.
12. Hao T, Shi W, Shen X, Qi J, Wu X, Wu Y, et al. Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer. Br J Cancer. 2014;111(8):1482-9.
13. Pinzani P, Salvianti F, Zaccara S, Massi D, De Giorgi V, Pazzagli M, et al. Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. Clin Chim Acta. 2011;412(23):2141-5.
14. Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas. 1998;17(1):89-97.
15. Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61(4):1659-65.
16. Kaiser J. Keeping tabs on tumor DNA. Science. 2010;327(5969):1074.
17. Jung K, Fleischhacker M, Rabien A. Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature. Clin Chim Acta. 2010;411(21):1611-24.
18. Murtaza M, Dawson S-J, Tsui DW, Gale D, Forshew T, Piskorz AM, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature. 2013;497(7447):108-12.
19. Deininger P. Alu elements: know the SINEs. Genome Biol. 2011;12(12):236.